Altered HDL proteome predicts incident CVD in chronic kidney disease patients
Open Access
- 9 October 2021
- journal article
- research article
- Published by Elsevier BV in Journal of Lipid Research
- Vol. 62, 100135
- https://doi.org/10.1016/j.jlr.2021.100135
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Diminished Antioxidant Activity of High-Density Lipoprotein-Associated Proteins in Chronic Kidney DiseaseJournal of the American Heart Association, 2013
- Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation studyThe Lancet, 2012
- High-Density Lipoprotein Cholesterol and Particle Concentrations, Carotid Atherosclerosis, and Coronary Events: MESA (Multi-Ethnic Study of Atherosclerosis)Journal of Invasive Cardiology, 2012
- Serum Amyloid A in Uremic HDL Promotes InflammationJournal of the American Society of Nephrology, 2012
- Antioxidant and anti-inflammatory role of paraoxonase 1: Implication in arteriosclerosis diseasesNorth American Journal of Medical Sciences, 2012
- Uremia Alters HDL Composition and FunctionJournal of the American Society of Nephrology, 2011
- Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and AtherosclerosisThe New England Journal of Medicine, 2011
- Skyline: an open source document editor for creating and analyzing targeted proteomics experimentsBioinformatics, 2010
- Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDLJCI Insight, 2007
- Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and HospitalizationThe New England Journal of Medicine, 2004